The RCS curves showed that the positive correlation between S100A12 and the risk of PAD was stronger when the S100A12 level was less than 1.00ng/cL, whereas when S100A12 level was greater than 1.00ng/cL, the correlation between the two was weaker. Here, S100A12 is linked to peripheral arterial disease.